Kong Lingheng, Peng Jianhong, Li Jibin, Wang Fulong, Li Cong, Ding Peirong, Li Liren, Chen Gong, Wu Xiaojun, Lu Zhenhai, Fang Yujing, Pan Zhizhong, Wan Desen
Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Ann Transl Med. 2019 Nov;7(21):608. doi: 10.21037/atm.2019.10.39.
Local or distant recurrence may develop beyond 5 years after radical resection for colorectal cancer (CRC). There is little evidence of a pattern of recurrence after the routinely recommended 5 years of follow-up. We aimed to investigate the efficacy of the prolonged follow-up beyond 5 years.
We retrospectively analyzed clinical and survival data of 1,054 CRC patients who underwent radical resections from 1980 to 1996 in our center. The prolonged surveillance was recommended for each patient with a duration of over 20 years.
The follow-up rates of 5, 10, 15, and 20 years were 92.6%, 86.9%, 82.3% and 76.8%, respectively. Overall survival (OS) rates of 5, 10, 15, and 20 years were 68.4%, 57.7%, 52.6% and 45.0%, respectively. Totally, 112 (10.6%) patients developed local recurrences and 174 (16.5%) patients developed distant metastases. The 99.2% postoperative local recurrences and distant metastases occurred within the first 15 years of surveillance. Survival differed between four age groups. Local recurrence was mainly diagnosed among rectal cancer patients, especially in those with lower-third rectal cancer. Metastases were commonly found in the liver and lungs. Patients with colon cancer and stage I/II manifested significantly longer OS than patients with rectal cancer and stage III/IV (both P<0.001).
In this study, postoperative local recurrences and distant metastases was rarely found after 15 years of enhanced surveillance, which indicated a "true cure" if the patient did not develop recurrences and metastases after 15 years.
结直肠癌(CRC)根治性切除术后5年以上可能发生局部或远处复发。在常规推荐的5年随访之后,几乎没有关于复发模式的证据。我们旨在研究5年以上延长随访的疗效。
我们回顾性分析了1980年至1996年在本中心接受根治性切除术的1054例CRC患者的临床和生存数据。建议对每位患者进行超过20年的延长监测。
5年、10年、15年和20年的随访率分别为92.6%、86.9%、82.3%和76.8%。5年、10年、15年和20年的总生存率(OS)分别为68.4%、57.7%、52.6%和45.0%。共有112例(10.6%)患者发生局部复发,174例(16.5%)患者发生远处转移。99.2%的术后局部复发和远处转移发生在监测的前15年内。四个年龄组的生存率有所不同。局部复发主要在直肠癌患者中诊断出来,尤其是在低位直肠癌患者中。转移常见于肝脏和肺部。结肠癌和I/II期患者的OS明显长于直肠癌和III/IV期患者(均P<0.001)。
在本研究中,强化监测15年后很少发现术后局部复发和远处转移,这表明如果患者在15年后未发生复发和转移,则为“真正治愈”。